SCHEMBL27652629

SCHEMBL27652629

CCc1cc(C(C)Br)ccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAP4K4 O95819 1/20 0.36
▸ SREBF1 P36956 1/20 0.35
▸ SREBF2 Q12772 1/20 0.35
▸ PRKCI P41743 1/20 0.34
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ SORD Q00796 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ AAK1 Q2M2I8 2/20 0.32
▸ CDC7 O00311 1/20 0.31
▸ DBF4 Q9UBU7 1/20 0.31
▸ RXRA P19793 1/20 0.30
▸ GRIN1 Q05586 1/20 0.30
▸ GRIN2B Q13224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11994370 0.84 CYP1A2 (0.46) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL17000203 0.81 CYP1A2 (0.43) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL28235461 0.81 CYP1A2 (0.43) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL18415133 0.81 CYP1A2 (0.47) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL19846685 0.81 CYP1A2 (0.47) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL14643122 0.81 CYP1A2 (0.43) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL19910242 0.76 CYP1A2 (0.42) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL20960558 0.76 CYP1A2 (0.46) CYP1A2POLBMAP4K4SREBF1SREBF2
SCHEMBL11266102 0.75 AKR1C3 (0.50) CYP1A2POLBKDM4ELMNACYP3A4
SCHEMBL29256500 0.74 CYP1A2 (0.45) CYP1A2POLBMAP4K4SREBF1SREBF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1768054-A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors AVENTIS PHARMA SA (FR) 2006-05-03 — — CN disclosed
Send feedback